Masi, Gabriele
Pfanner, Chiara
Liboni, Francesca
Lenzi, Francesca
Villafranca, Arianna
D’Acunto, Giulia
Fantozzi, Pamela
Falcone, Francesca
Simonelli, Valerio
Muratori, Pietro
Levantini, Valentina
Favole, Irene
Amianto, Federico
Davico, Chiara
Vitiello, Benedetto http://orcid.org/0000-0002-8093-7383
Funding for this research was provided by:
Ministero della Salute (Not available)
Article History
Accepted: 10 January 2022
First Online: 9 February 2022
Declarations
:
: Italian Ministry of Health: Ricerca Corrente (Gabriele Masi, Project 2.02: <i>Attention-Deficit/ Hyperactivity Disorder (ADHD): Phenotypic Specifiers and Treatment Implications</i>), and public voluntary contributions under the program “5 per 1000”.
: In the last 2 years, GM was a member of advisory boards for Angelini Pharmaceuticals, received institutional grants from Lundbeck and Humana, and was a speaker for Angelini, FB Health, Janssen, Lundbeck, and Otsuka. BV has received consultant fees or honoraria from Medice, Lundbeck, and Angelini Pharmaceuticals, and from law firms Goodwin & Procter and Haynes & Boone. The other authors report no biomedical financial interests or potential conflicts of interest.
: All the parents signed written informed consent for their child to receive the assessment procedure, the first-dose test, and the subsequent pharmacological treatment, according to the standard operative procedure defined by the Italian Ministry of Health. The protocol (Italian ADHD National Registry) has been approved by the Italian Ministry of Health.
: Not applicable.
: Not applicable.
: Conceptualization: GM and BV; design and methods: GM, CP and BV; data collection: FL, FL, AV, GD, PF, and IF; data management: FF, VS, PM, and VL; manuscript preparation: GM and BV; review and editing: CP, FL, FL, AV, GD, PF, FF, VS, PM, VL, IF, FA, and CD. All authors approved the published version of the manuscript and agreed to be accountable for the work outlined in the manuscript.
: Study data are available from the authors upon reasonable request.
: The protocol (Italian ADHD registry) has been completed and approved by the Italian Ministry of Health. Anonymized data from registry, with parental consent to inclusion.